Forecasted import volumes of penicillins and streptomycins in dosage forms to Germany show a steady growth trend, from 5.1054 million kilograms in 2024 to 5.5002 million kilograms by 2028. Compared to the actual 2023 import value, which was recorded at 5.002 million kilograms, forecasted volumes portray a consistent annual increase of approximately 2% to 2.5% per year. This reflects a compound annual growth rate (CAGR) of about 1.9% over the five-year horizon.

Future trends to watch for include:

Fluctuations in global supply chains due to geopolitical or economic factors may impact import volumes.
Regulatory changes in pharmaceutical imports could alter the market dynamics significantly.
Technological advancements and shifts in healthcare practices might influence demand for specific drug formulations.